Squarepoint Ops LLC Karyopharm Therapeutics Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.84 - $3.92 $112,833 - $155,741	-39,730 Reduced 75.99%	12,553 $48,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $129,661 - $310,038	52,283 New	52,283 $177,000
Q1 2022 May 16, 2022	SELL	$5.91 - $14.38 $734,459 - $1.79 Million	-124,274 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $647,467 - $1.07 Million	124,274 New	124,274 $799,000
Q3 2021 Nov 15, 2021	SELL	$4.45 - $10.63 $153,120 - $365,767	-34,409 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.11 - $11.11 $279,056 - $382,283	34,409 New	34,409 $355,000
Q1 2021 May 17, 2021	SELL	$9.85 - $17.69 $788,522 - $1.42 Million	-80,053 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$14.15 - $17.19 $1.11 Million - $1.35 Million	-78,470 Reduced 49.5%	80,053 $1.24 Million
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $1.66 Million - $2.31 Million	117,173 Added 283.37%	158,523 $2.31 Million
Q2 2020 Aug 14, 2020	SELL	$16.6 - $25.25 $263,857 - $401,348	-15,895 Reduced 27.77%	41,350 $783,000
Q1 2020 May 15, 2020	BUY	$14.38 - $27.72 $487,007 - $938,793	33,867 Added 144.87%	57,245 $1.1 Million
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $215,778 - $459,845	23,378 New	23,378 $448,000
Q3 2019 Nov 14, 2019	SELL	$5.66 - $11.85 $110,698 - $231,762	-19,558 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.32 - $6.43 $84,490 - $125,757	19,558 New	19,558 $117,000
Q1 2019 May 15, 2019	SELL	$4.12 - $10.25 $217,606 - $541,374	-52,817 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.2 - $16.95 $5,879 - $12,153	717 Added 1.38%	52,817 $495,000
Q3 2018 Nov 14, 2018	BUY	$17.03 - $21.18 $636,922 - $792,132	37,400 Added 254.42%	52,100 $887,000
Q2 2018 Aug 14, 2018	BUY	$12.0 - $19.88 $176,400 - $292,236	14,700 New	14,700 $250,000
Q1 2018 May 15, 2018	SELL	$9.92 - $17.25 $127,938 - $222,473	-12,897 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$9.15 - $11.99 $118,007 - $154,635	12,897	12,897 $124,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

56.5M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$4.75 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.44 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.16 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.68 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.59 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $49.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account